Search Results 811-820 of 17861 for Assay

  1. Controlled Trial Evaluating Avacopan in C3 Glomerulopathy - Mayo Clinic

    ... assay. Currently on dialysis or likely will require dialysis within 7 days after screening. History or presence of any form of cancer within the 5 years ...

  2. Testing Low Dose Tamoxifen For Invasive Breast Cancer, The (LoTam) Trial - Mayo Clinic

    ... assay was obtained, both are required to be low-risk): * Oncotype DX recurrence score ≤ 25 * Mamma Print low risk * Prosigna risk of recurrence ≤ 40 * ...

  3. Autologous Stem Cell Transplant Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the clinical performance of the Aptima CMV Quant assay on the Panther system in ethylenediaminetetraacetic acid (EDTA) ...

  4. Projects - Neurobiology of Alcoholism and Drug Addiction Laboratory - Mayo Clinic Research

    We assessed apolipoprotein E (ApoE) in the brain of APP/PS1 mice using immunohistochemistry and enzyme-linked immunosorbent assay in response to low to moderate ...

  5. Brain Tumor Program - Clinical trials

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  6. Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome - Mayo Clinic

    Measurable light chains by free light chain assay; Measurable plasmacytoma; Monoclonal plasma cells in bone marrow. Eastern Cooperative Oncology Group (ECOG) ...

  7. A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (SubQSA) - Mayo Clinic

    Serum free light chain (FLC) assay: Involved FLC assay ≥10 mg/dL (≥100 mg/L) and an abnormal serum FLC ratio (<0.26 or >1.65). Participants with relapsed ...

  8. Graft-Versus-Host Disease Clinical Trials - Mayo Clinic Research

    ... assay, the aim is to perform a multi-institution, retrospective study of our assay compared with the current clinical gold standard (clinicopathologic ...

  9. Clinical trials - Oncology (Medical)

    ... assayed from blood of cases with CAP and controls without history of cancer. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL. Rochester, Minn., Scottsdale/Phoenix ...

  10. Thyroid Autoimmunity Biobank - Clinical Trials

    TPO antibodies >9 IU/L or ULN for the assay; US pattern or cytology or pathology consistent with HT. Graves' Orbitopathy. ≥18 years of age; Presence of ...